Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent
Authors
Keywords
-
Journal
PHARMACOTHERAPY
Volume 35, Issue 11, Pages 1037-1051
Publisher
Wiley
Online
2015-11-02
DOI
10.1002/phar.1652
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Phase 2, Randomized, Double-Blind, Multicenter Trial To Evaluate the Safety and Efficacy of Three Dosing Regimens of Isavuconazole Compared with Fluconazole in Patients with Uncomplicated Esophageal Candidiasis
- (2015) J. Viljoen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and Pharmacokinetics of Isavuconazole as Antifungal Prophylaxis in Acute Myeloid Leukemia Patients with Neutropenia: Results of a Phase 2, Dose Escalation Study
- (2015) Oliver A. Cornely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for the Cryptococcus neoformans-Cryptococcus gattii Species Complex Using the CLSI M27-A3 Broth Microdilution Method
- (2014) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroAntifungal Activity of Isavuconazole against 345 Mucorales Isolates Collected at Study Centers in Eight Countries
- (2014) P.E. Verweij et al. JOURNAL OF CHEMOTHERAPY
- Isavuconazole Treatment of a Patient with Disseminated Mucormycosis
- (2014) D. Peixoto et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer
- (2014) B. C. Monk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Determination of Isavuconazole Susceptibility of Aspergillus and Candida Species by the EUCAST Method
- (2013) Susan J. Howard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isavuconazole Pharmacodynamic Target Determination for Candida Species in anIn VivoMurine Disseminated Candidiasis Model
- (2013) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isavuconazole (BAL4815) Pharmacodynamic Target Determination in anIn VivoMurine Model of Invasive Pulmonary Aspergillosis against Wild-Type andcyp51Mutant Isolates of Aspergillus fumigatus
- (2013) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for Aspergillus spp. for the CLSI M38-A2 Broth Microdilution Method
- (2013) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of intravenous voriconazole in patients with compromised renal function
- (2013) Craig M Lilly et al. BMC INFECTIOUS DISEASES
- Successful isavuconazole salvage therapy in a patient with invasive mucormycosis
- (2013) J. Ervens et al. INFECTION
- Isavuconazole Activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, Emerging Fungal Pathogens with Reduced Azole Susceptibility
- (2013) K. Datta et al. JOURNAL OF CLINICAL MICROBIOLOGY
- In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds
- (2013) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Risk factors for early mortality in haematological malignancy patients with pulmonary mucormycosis
- (2013) Russell E. Lewis et al. MYCOSES
- Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study
- (2013) Russell E. Lewis et al. MYCOSES
- Posaconazole Pharmacodynamic Target Determination against Wild-Type andCyp51Mutant Isolates of Aspergillus fumigatus in anIn VivoModel of Invasive Pulmonary Aspergillosis
- (2012) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiology and Clinical Manifestations of Mucormycosis
- (2012) George Petrikkos et al. CLINICAL INFECTIOUS DISEASES
- Mucormycosis treated with posaconazole: review of 96 case reports
- (2012) Joerg J. Vehreschild et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3)
- (2012) A. Skiada et al. HAEMATOLOGICA
- How I treat mucormycosis
- (2011) D. P. Kontoyiannis et al. BLOOD
- Use of antifungal agents in pediatric and adult high-risk areas
- (2011) E. Ramírez et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Three-dimensional models of 14α-sterol demethylase (Cyp51A) from Aspergillus lentulus and Aspergillus fumigatus: an insight into differences in voriconazole interaction
- (2011) Laura Alcazar-Fuoli et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success
- (2010) D P Kontoyiannis BONE MARROW TRANSPLANTATION
- Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)
- (2010) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- Isavuconazole: A Comprehensive Review of Spectrum of Activity of a New Triazole
- (2010) George R. Thompson et al. MYCOPATHOLOGIA
- In Vitro Activity of the New Azole Isavuconazole (BAL4815) Compared with Six Other Antifungal Agents against 162 Cryptococcus neoformans Isolates from Cuba
- (2008) M.-T. Illnait-Zaragozi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Antifungal Activities of Isavuconazole (BAL4815), Voriconazole, and Fluconazole against 1,007 Isolates of Zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium Species
- (2008) J. Guinea et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
- (2008) Ben De Pauw et al. CLINICAL INFECTIOUS DISEASES
- Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry
- (2008) D. Neofytos et al. CLINICAL INFECTIOUS DISEASES
- Pediatric Antifungal Utilization
- (2008) Priya A. Prasad et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search